Log in to save to my catalogue

Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation...

Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153666074

Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial

About this item

Full title

Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial

Publisher

Elsevier Ltd

Journal title

Vaccine, 2023-10, Vol.41 (45), p.6700-6709

Language

English

Formats

Publication information

Publisher

Elsevier Ltd

More information

Scope and Contents

Contents

Highlights•MAPC surveillance improves AEFI detection compared with passive surveillance. •In some LMIC’s AEFI reporting rates do not meet the WHO benchmarks. •Such countries should explore digital solutions to enhance surveillance. •Subsidized mHealth solutions should be explored to reduce barriers to reporting.

Alternative Titles

Full title

Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3153666074

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153666074

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2023.09.037

How to access this item